Skip to content

PEPFAR success critically dependent on use of generic ARVs, study shows

It's conference countdown here at NAM and the office is a hive of activity

It's conference countdown here at NAM and the office is a hive of activity

Welcome to the new aidsmap.com and welcome to our blog!

Welcome to the new aidsmap.com and welcome to our blog!

Merck stops development of CCR5 inhibitor vicriviroc

Maraviroc potentially useful if neurological disease is present

Towards more compassionate care for people with drug-resistant TB

Towards more compassionate care for people with drug-resistant TB

UNAIDS calls for radical simplification of treatment to support HIV prevention

HIV cure efforts severely underfunded, US activists report

CD4 cell count below 500 associated with increased risk of CVD - implications for 'when to start' debate